Literature DB >> 6775103

Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens.

E I Galaid, C E Cherubin, J S Marr, S Schaefler, J Barone, W Lee.   

Abstract

In the period 1973 through 1978, the New York City Department of Health serogrouped 648 isolates of Neisseria meningitidis and investigated 259 cases if meningococcal meningitis and meningococcemia. Although meningitis and septicemia were mainly due to groups B and C, groups Y and W-135 caused nearly one third of the cases. There was no difference in mortalities when disease caused by the classic groups A, B, and C was compared with disease caused by the new serogroups X, Y, Z, W-135, and Z'. Most isolates from the respiratory tract were from the new serogroups, especially Z and Z' (some from patients with pneumonia), as were most of those from the genitourinary tract, anal canal, and miscellaneous sites. Group X was infrequently seen. Although most of the isolations of these groups of N meningitidis are apparently from asymptomatic carriers, Y and W-135 do cause a substantial number of acute symptomatic infections, in particular, septicemia.

Entities:  

Mesh:

Year:  1980        PMID: 6775103

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

Review 1.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Neisseria meningitidis serogroup 29E (Z') septicemia in a patient with far advanced multiple myeloma (plasma cell leukemia).

Authors:  E Wachter; A E Brown; T E Kiehn; B J Lee; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

Review 3.  A complicated simple fall--an atypical case of serogroup Y meningococcal pneumonia with secondary septicaemia and literature review.

Authors:  B K Y Chan; S Kudsk-Iversen; S Balaguruswamy; T S Purewal
Journal:  BMJ Case Rep       Date:  2012-04-04

Review 4.  Epidemiological profile of meningococcal disease in the United States.

Authors:  Lee H Harrison
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

5.  Decreased susceptibility to penicillin G and Tet M plasmids in genital and anorectal isolates of Neisseria meningitidis.

Authors:  K K Winterscheid; W L Whittington; M C Roberts; J R Schwebke; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

6.  Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.

Authors:  J M Griffiss; B L Brandt; P L Altieri; G B Pier; S L Berman
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  Meningococcal infections in Scotland 1972-82.

Authors:  R J Fallon; W M Brown; W Lore
Journal:  J Hyg (Lond)       Date:  1984-10

8.  Characteristics of pathogenic Neisseria spp. isolated from homosexual men.

Authors:  W M Janda; J A Morello; S A Lerner; M Bohnhoff
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

9.  Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide.

Authors:  I Vodopija; Z Baklaic; P Hauser; P Roelants; F E André; A Safary
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.

Authors:  L Spanjaard; P Bol; S de Marie; H C Zanen
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.